Stock 3164 GENMONT BIOTECH INCORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials GenMont Biotech Incorporation

Equities

3164

TW0003164000

Food Processing

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
23.3 TWD +0.87% Intraday chart for GenMont Biotech Incorporation +6.15% -5.67%
Mar. 12 GenMont Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 07 GenMont Biotech Incorporation Proposes Cash Dividend for the Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,374 2,214 1,925 2,103 2,047 2,137
Enterprise Value (EV) 1 1,447 1,721 1,495 1,714 1,681 1,867
P/E ratio 15.1 x 38.9 x 32.3 x 18.7 x 35.9 x 65 x
Yield 5.62% 3.21% 3.14% 4.52% 2.95% -
Capitalization / Revenue 5.84 x 6.4 x 5.92 x 4.91 x 5.55 x 6.72 x
EV / Revenue 3.56 x 4.97 x 4.6 x 4.01 x 4.56 x 5.87 x
EV / EBITDA 9.76 x 18 x 16.8 x 12 x 15.3 x 27.1 x
EV / FCF -6.22 x -5.74 x -35.9 x -709 x 21.4 x -1,188 x
FCF Yield -16.1% -17.4% -2.78% -0.14% 4.68% -0.08%
Price to Book 1.59 x 1.6 x 1.45 x 1.53 x 1.51 x 1.62 x
Nbr of stocks (in thousands) 88,912 88,934 86,341 86,371 86,371 86,511
Reference price 2 26.70 24.90 22.30 24.35 23.70 24.70
Announcement Date 3/29/19 3/31/20 3/24/21 3/23/22 3/15/23 3/12/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 406.5 346.2 325.2 427.9 368.5 318
EBITDA 1 148.3 95.69 88.77 143.1 109.9 68.77
EBIT 1 122.2 77.61 70.97 125 61.97 6.988
Operating Margin 30.05% 22.41% 21.82% 29.22% 16.81% 2.2%
Earnings before Tax (EBT) 1 123.9 75.54 76.85 139.4 66.26 28.16
Net income 1 158 57.45 60.88 113.1 56.98 32.99
Net margin 38.87% 16.59% 18.72% 26.44% 15.46% 10.37%
EPS 2 1.766 0.6400 0.6900 1.300 0.6597 0.3800
Free Cash Flow 1 -232.7 -299.6 -41.58 -2.417 78.65 -1.572
FCF margin -57.23% -86.53% -12.79% -0.56% 21.34% -0.49%
FCF Conversion (EBITDA) - - - - 71.56% -
FCF Conversion (Net income) - - - - 138.04% -
Dividend per Share 2 1.500 0.8000 0.6998 1.100 0.7000 -
Announcement Date 3/29/19 3/31/20 3/24/21 3/23/22 3/15/23 3/12/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 927 494 431 389 366 270
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -233 -300 -41.6 -2.42 78.7 -1.57
ROE (net income / shareholders' equity) 6.69% 3.8% 4.11% 7.29% 3.14% 1.52%
ROA (Net income/ Total Assets) 4.84% 3% 2.79% 4.72% 2.28% 0.26%
Assets 1 3,268 1,913 2,185 2,397 2,496 12,650
Book Value Per Share 2 16.80 15.60 15.40 15.90 15.60 15.20
Cash Flow per Share 2 2.530 2.160 3.180 1.970 1.550 0.6400
Capex 1 275 394 139 117 71.2 33.3
Capex / Sales 67.67% 113.71% 42.67% 27.33% 19.32% 10.47%
Announcement Date 3/29/19 3/31/20 3/24/21 3/23/22 3/15/23 3/12/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
GENMONT BIOTECH INCORPORATION Stock GenMont Biotech Incorporation
-5.67% 61.91M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+13.21% 8.15B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
-0.47% 7.27B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+12.30% 6.65B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.99% 3.72B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-6.63% 3.67B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-4.78% 1.31B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+12.61% 972M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-12.16% 876M
HERBALIFE LTD. Stock Herbalife Ltd.
-37.65% 866M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. 3164 Stock
  4. Financials GenMont Biotech Incorporation